.png){kind=icon}
.png){kind=icon}
Return
Purinergic receptors in the carotid body as a new drug target for controlling hypertension
.png){kind=icon}
OA
AI
W
D
L
A
E
M
B
F
A
A
J
DOI：10.1038/nm.4173.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In view of the high proportion of individuals with resistance to antihypertensive medication and/or poor compliance or tolerance of this medication, new drugs to treat hypertension are urgently needed. Here we show that peripheral chemoreceptors generate aberrant signaling that contributes to high blood pressure in hypertension. We discovered that purinergic receptor P2X3 (P2rx3, also known as P2x3) mRNA expression is upregulated substantially in chemoreceptive petrosal sensory neurons in rats with hypertension. These neurons generate both tonic drive and hyperreflexia in hypertensive (but not normotensive) rats, and both phenomena are normalized by the blockade of P2X3 receptors. Antagonism of P2X3 receptors also reduces arterial pressure and basal sympathetic activity and normalizes carotid body hyperreflexia in conscious rats with hypertension; no effect was observed in rats without hypertension. We verified P2X3 receptor expression in human carotid bodies and observed hyperactivity of carotid bodies in individuals with hypertension. These data support the identification of the P2X3 receptor as a potential new target for the control of human hypertension.
Keywords:
BLOOD-PRESSURE
ARTERIOVENOUS ANASTOMOSIS
ARTERIAL CHEMORECEPTORS
SYMPATHETIC ACTIVITY
THERAPEUTIC TARGET
P2X3 RECEPTORS
TASK CHANNELS
ATP
RAT
RESPONSES
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
50
Papers:
1.4W
Citations:
13.4W
Organization
Cited Papers